Intuitive Surgical (NASDAQ:ISRG) Shares Up 1.3% – Here’s Why

Intuitive Surgical, Inc. (NASDAQ:ISRG)’s stock price was up 1.3% during mid-day trading on Thursday . The company traded as high as $584.08 and last traded at $580.02. Approximately 400,239 shares traded hands during mid-day trading, a decline of 79% from the average daily volume of 1,931,788 shares. The stock had previously closed at $572.71.

Wall Street Analyst Weigh In

Several research firms recently commented on ISRG. Citigroup raised their target price on Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research note on Friday, January 24th. Robert W. Baird boosted their target price on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research report on Thursday, October 17th. Erste Group Bank upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. Evercore ISI upped their price objective on shares of Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. Finally, Leerink Partners raised their target price on Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have issued a buy rating to the company. According to data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average price target of $613.10.

Intuitive Surgical Stock Down 1.4 %

The stock has a 50-day moving average of $550.40 and a 200 day moving average of $508.94. The company has a market capitalization of $203.69 billion, a PE ratio of 89.22, a P/E/G ratio of 5.52 and a beta of 1.39.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, CFO Jamie Samath sold 94 shares of the business’s stock in a transaction on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total value of $53,684.34. Following the sale, the chief financial officer now directly owns 2,630 shares in the company, valued at $1,502,019.30. The trade was a 3.45 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the sale, the director now directly owns 12,275 shares in the company, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 28,843 shares of company stock worth $15,357,560 in the last ninety days. Company insiders own 0.90% of the company’s stock.

Hedge Funds Weigh In On Intuitive Surgical

A number of large investors have recently made changes to their positions in the stock. Mirador Capital Partners LP grew its holdings in Intuitive Surgical by 1.4% during the 3rd quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock valued at $1,732,000 after buying an additional 50 shares in the last quarter. M.E. Allison & CO. Inc. bought a new position in shares of Intuitive Surgical in the fourth quarter worth $449,000. Seilern Investment Management Ltd bought a new stake in Intuitive Surgical during the fourth quarter valued at $82,517,000. Exome Asset Management LLC raised its holdings in shares of Intuitive Surgical by 16.8% in the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock valued at $3,649,000 after acquiring an additional 1,069 shares in the last quarter. Finally, Consolidated Planning Corp grew its holdings in shares of Intuitive Surgical by 17.4% during the third quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock worth $3,979,000 after purchasing an additional 1,198 shares in the last quarter. 83.64% of the stock is owned by institutional investors.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.